市場今すぐ寄付してください会員になる

カート (0)

DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか？ or パスワードをお忘れですか？

Not a Member?

アカウントを作成して参加。

世界的なイベント

東京ビッグサイト

2017年11月12日 (日) 午前 9:30 - 2017年11月14日 (火) 午後 5:30

〒135-0063, 東京都江東区有明3-11-1

第14回DIA日本年会

戻る Agenda

[V5-S2] Approaches to Enhance Appropriate Communication on Pharmaceutical Product Information

Session Chair(s)

Mamoru Narukawa, PhD, RPh

Mamoru Narukawa, PhD, RPh

Professor, Kitasato University, Japan

Yuko Kojima, RPh

Yuko Kojima, RPh

Sr. Executive Director, Eli Lilly Japan K.K., Japan

It is highly important that pharmaceutical product information is appropriately provided by regulatory authorities and pharmaceutical companies, and utilized in the medical field. In the Japan annual meeting in 2016, we discussed issues arising from provision of pharmaceutical product information materials provided to healthcare professionals or patients, and handling of these issues. We have found that pharmaceutical product information is not necessarily fully utilized by the medical professionals: duplicate information is provided using various materials from the regulatory authorities and companies, necessary information for medical professionals is not provided, and the real intentions of the authors are not fully conveyed. In 2017, we will discuss approaches and future perspectives to enhance appropriate communication on pharmaceutical product information to medical professionals based on the previous discussion by summarizing the objectives and utilization methods of a wide range of information materials provided by the regulatory authorities and companies.

Speaker(s)

Provision of Drug Information by Regulators: Overview and Challenges

Tomoko Tanita

Risk Communication Promotion Division, Office of Safety I, Pharmaceuticals and Medical Devices Agency (PMDA), Japan

Susumu Wakabayashi

Proposals for Providing Drug Information from the Viewpoint of Medical Staff

Susumu Wakabayashi

Department of Pharmacy, Kyorin University Hospital, Japan

Shinya Takemoto, MSc

To Enable the Patient Centered Risk Communication -The Industry Perspective-

Shinya Takemoto, MSc

Group Manager, Safety Information Strategy Group, Risk Communication Department, Chugai Pharmaceutical Co., Ltd., Japan

Junichi Nishino, MSc, RPh

Information Required by Medical Institutions and Judgment of Provision for it from Industries Point of View

Junichi Nishino, MSc, RPh

Head, Regulatory Affairs Department, Otsuka Pharmaceutical Co., Ltd., Japan